Gerhard Falkenhorst

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Particulate Matter

Health Insurance

Respiratory Syndrome Coronavirus

Top Venues

Epidemiology and infection

This page only lists publications with an associated author ORCID identifier.

Publications

Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, Maren Enßle, Andreas Hicketier, Achim Dörre, Klaus Stark, Hendrik Wilking
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study). Epidemiology and infection 152 (2024)
Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, Maren Enßle, Andreas Hicketier, Achim Dörre, Klaus Stark, Hendrik Wilking
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study). Epidemiology and infection 152 (2024)
Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, Maren Enßle, Andreas Hicketier, Achim Dörre, Klaus Stark, Hendrik Wilking
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study). Epidemiology and infection 152 (2024)
Bettina M Rosner, Gerhard Falkenhorst, Isabella Kumpf, Maren Enßle, Andreas Hicketier, Achim Dörre, Klaus Stark, Hendrik Wilking
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study). Epidemiology and infection 152 (2024)
Gerhard Falkenhorst, Cornelius Remschmidt, Thomas Harder, Eva Hummers-Pradier, Ole Wichmann, Christian Bogdan
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PloS one 12 (1) (2017)